Delivery Order SPE2DR25D7055-SPE2DR26FV5RA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Escitalopram 20 mg tablets in a quantity of 1,000 units, with a firm fixed price ceiling value of $4,295.66. The contract represents a non-set-aside, competitively awarded procurement with an ultimate completion date of September 2, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Escitalopram 20 mg tablets in quantities of 1,000 units, valued at $2,255.76 with a firm fixed price structure. The award was made on November 14, 2025, with an ultimate completion date of November 17, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of 1,000 tablets of Escitalopram 20 mg, with a contract ceiling value of $3,927.42 and an ultimate completion date of June 3, 2025. This non-competitive, firm fixed-price delivery order was placed without any set-aside designation. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $1,711.70 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of 1,000 tablets of Escitalopram 10 mg, with completion scheduled for September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,395.86 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of 1,000 tablets of Escitalopram 10 mg. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg under a firm fixed-price contract valued at $2,440.44. The order was competitively awarded without a set-aside designation and is scheduled for completion by October 30, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Escitalopram 20 mg tablets (90-count units) under a firm fixed-price contract valued at $1,156.44. The award was made on August 15, 2025, with an ultimate completion date of August 18, 2025, and does not include a set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on November 18, 2025, for 1,000 tablets of Escitalopram 20 mg. This is a firm fixed-price, competitively awarded contract with a ceiling value of $1,755.18 and an ultimate completion date of November 19, 2025. The contract contains no set-aside designation and is being performed at the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of 1,000 tablets of Escitalopram 10 mg, valued at $3,558.49 under a firm fixed-price contract. This delivery order represents a non-competitive, non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The pharmaceutical product is...
- The Defense Logistics Agency awarded a delivery order valued at $3,562.33 to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on August 22, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary operations. This delivery...
- SPE2DR25D7055Indefinite Delivery Contract
- SPE2DR25D7055-SPE2DR26FV5RADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Escitalopram 20 mg tablets in a quantity of 1,000 units, with a ceiling value of $1,053.38. This is a firm fixed-price delivery order with an ultimate completion date of December 8, 2025. The contract involves no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The parent contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/4/25 |